Atea Pharmaceuticals, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes repurchases of our common stock during the three months ended September 30, 2025:
| Period · Total Number of Shares Purchased · Average Price Paid per Share (1) · Total Number of Shares Repurchased as Part of a Publicly Announced Plan or Program · Maximum Value of Shares that May Yet be Repurchased Under the Plan or Program (1) | ||||||
|---|---|---|---|---|---|---|
| July 1 - 31 | 1,714,700 | $3.69 | 1,714,700 | $4,766 | ||
| August 1 - 31 | 1,339,495 | $3.56 | 1,339,495 | $ | - | |
| September 1 - 30 | - | $ | - | - | $ | - |
| Total | 3,054,195 | $3.63 | 3,054,195 | $ | - | |
| (1) Excludes transaction costs and excise taxes. | ||||||
On April 17, 2025, we publicly announced that our Board of Directors approved a stock repurchase program (the “Share Repurchase Program”), authorizing the repurchase of up to $25.0 million of the Company’s common stock (“Common Stock”). As of September 30, 2025, we have completed the Share Repurchase Program.
Under the Share Repurchase Program, we repurchased a total of 7,673,792 shares of Common Stock, including 3,054,195 shares of Common Stock repurchased during the three months ended September 30, 2025. All repurchases were made in the open market through a trading plan that was adopted by the Company in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended or through privately negotiated transactions. All repurchases were made in accordance with Rule 10b-18 under the Exchange Act and were funded using cash on hand. For information regarding our Share Repurchase Program, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations. – Financial Resources.
Recent Sales of Unregistered Securities
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.